Jia SF - Search Results

1

Fas expression inversely correlates with metastatic potential in osteosarcoma cells.

Worth LL, Lafleur EA, Jia SF, Kleinerman ES. Worth LL, et al. Among authors: jia sf. Oncol Rep. 2002 Jul-Aug;9(4):823-7. Oncol Rep. 2002. PMID: 12066216

2

Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector.

Jia SF, Worth LL, Densmore CL, Xu B, Zhou Z, Kleinerman ES. Jia SF, et al. Cancer Gene Ther. 2002 Mar;9(3):260-6. doi: 10.1038/sj.cgt.7700432. Cancer Gene Ther. 2002. PMID: 11896442

3

Eradication of osteosarcoma lung metastasis using intranasal gemcitabine.

Jia SF, Worth LL, Turan M, Duan Xp XP, Kleinerman ES. Jia SF, et al. Anticancer Drugs. 2002 Feb;13(2):155-61. doi: 10.1097/00001813-200202000-00007. Anticancer Drugs. 2002. PMID: 11901308

4

Aerosol gene therapy with PEI: IL-12 eradicates osteosarcoma lung metastases.

Jia SF, Worth LL, Densmore CL, Xu B, Duan X, Kleinerman ES. Jia SF, et al. Clin Cancer Res. 2003 Aug 15;9(9):3462-8. Clin Cancer Res. 2003. PMID: 12960138

5

Interleukin-12 enhances the sensitivity of human osteosarcoma cells to 4-hydroperoxycyclophosphamide by a mechanism involving the Fas/Fas-ligand pathway.

Duan X, Zhou Z, Jia SF, Colvin M, Lafleur EA, Kleinerman ES. Duan X, et al. Among authors: jia sf. Clin Cancer Res. 2004 Jan 15;10(2):777-83. doi: 10.1158/1078-0432.ccr-1245-02. Clin Cancer Res. 2004. PMID: 14760101

6

Increased Fas expression reduces the metastatic potential of human osteosarcoma cells.

Lafleur EA, Koshkina NV, Stewart J, Jia SF, Worth LL, Duan X, Kleinerman ES. Lafleur EA, et al. Among authors: jia sf. Clin Cancer Res. 2004 Dec 1;10(23):8114-9. doi: 10.1158/1078-0432.CCR-04-0353. Clin Cancer Res. 2004. PMID: 15585647

7

Association of alphavbeta3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cells.

Duan X, Jia SF, Zhou Z, Langley RR, Bolontrade MF, Kleinerman ES. Duan X, et al. Among authors: jia sf. Clin Exp Metastasis. 2004;21(8):747-53. doi: 10.1007/s10585-005-0599-6. Clin Exp Metastasis. 2004. PMID: 16035619

8

Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases.

Duan X, Jia SF, Koshkina N, Kleinerman ES. Duan X, et al. Among authors: jia sf. Cancer. 2006 Mar 15;106(6):1382-8. doi: 10.1002/cncr.21744. Cancer. 2006. PMID: 16453328 Free article.

9

Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine.

Gordon N, Koshkina NV, Jia SF, Khanna C, Mendoza A, Worth LL, Kleinerman ES. Gordon N, et al. Among authors: jia sf. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4503-10. doi: 10.1158/1078-0432.CCR-07-0313. Clin Cancer Res. 2007. PMID: 17671136 Free PMC article.

10

VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells.

Jia SF, Guan H, Duan X, Kleinerman ES. Jia SF, et al. J Exp Ther Oncol. 2008;7(2):89-97. J Exp Ther Oncol. 2008. PMID: 18771083 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters